Lenvatinib as a Promising Treatment Option for Unresectable Hürthle Cell Carcinoma: A Case Report

Hürthle cell carcinoma (HCC) of the thyroid gland generally has a more aggressive clinical course than other differentiated thyroid cancers (DTCs), and it is associated with a higher rate of distant metastases. In this case report, we highlight the importance of tyrosine kinase inhibitors as a manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirode, Parth S, D'cruz, Anil, Chatterjee, Sataksi, Bhandarkar, Swayambhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175712/
https://www.ncbi.nlm.nih.gov/pubmed/37187624
http://dx.doi.org/10.7759/cureus.37460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175712/
https://www.ncbi.nlm.nih.gov/pubmed/37187624
http://dx.doi.org/10.7759/cureus.37460

Ejemplares similares